Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Change in Acquisitions & Divestments (2020 - 2025)

Roivant Sciences (ROIV) has disclosed Change in Acquisitions & Divestments for 4 consecutive years, with $1.1 billion as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Acquisitions & Divestments changed N/A year-over-year to $1.1 billion, compared with a TTM value of $2.8 billion through Sep 2025, changed N/A, and an annual FY2025 reading of $2.0 billion, changed N/A over the prior year.
  • Change in Acquisitions & Divestments was $1.1 billion for Q3 2025 at Roivant Sciences, up from $720.0 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $1.1 billion in Q3 2025 and bottomed at $320.2 million in Q4 2021.
  • Average Change in Acquisitions & Divestments over 3 years is $776.3 million, with a median of $840.0 million recorded in 2024.
  • Peak annual rise in Change in Acquisitions & Divestments hit 200.0% in 2021, while the deepest fall reached 200.0% in 2021.
  • Year by year, Change in Acquisitions & Divestments stood at $320.2 million in 2021, then skyrocketed by 199.84% to $960.0 million in 2024, then rose by 15.1% to $1.1 billion in 2025.
  • Business Quant data shows Change in Acquisitions & Divestments for ROIV at $1.1 billion in Q3 2025, $720.0 million in Q2 2025, and $960.0 million in Q4 2024.